CONTACT
API Products
API Sourcing
Strategic Sourcing
505(b)(2) Pathway
Regulatory Support
Logistics
Manufacturer Management Program
CDMO Services
Formulation Development
Solid Dose Delivery Systems
Liquids / Suspensions
Semi-Solids
Suppositories
Commercial Scale-Up Facilities & Equipment
Regulatory Management
Analytical Services
Analytical Testing
Stability Services
Resources
About LGM
Quality Commitment
Leadership
Company History
Clients
News
Events
Careers
Blog
Contact
Blog
Sharing Our Expertise
How to Stay Compliant in a Changing Pharma Regulatory Landscape
December 06, 2019
In 2012, contaminated medications from the New England Compounding Center (NECC) caused a meningitis...
Read More >
Understanding 505(b)(2) Drug Development & API Supply Issues
November 04, 2019
Situated between the NDA and the ANDA is an increasingly popular drug commercialization pathway – the...
Read More >
Behind the Scenes with LGM Pharma’s API Sourcing Team
October 02, 2019
Running a marathon is just like what we do here at LGM Pharma – and in more ways than one, as it turns...
Read More >
9 Key Sourcing Challenges for Small Pharma
September 05, 2019
Pharma and biopharmaceutical supply chains continue to grow more complex & global. The process of...
Read More >
Previous
1
2
3
4
Search
Categories
Categories
505b2
Analytical Services
API Sourcing
blog
Bulk Active Ingredient
CDMO Services
Dosage Forms
Drug Manufacturing
Drug Research & Development API
Formulation Development
LGM Pharma
Liquids/Suspensions
Logistics
Manufacturer Qualification
Press Release
Regulatory Management
Regulatory Support
Semi-Solids
Solid Dose
Strategic Sourcing
Supply Chain
